Albany, Costantine

Phase II Trial of Pembrolizumab in Patients with Platinum Refractory Germ-Cell Tumors: A Hoosier Cancer Research Network Study GU14-206

Adra, N., Einhorn, L. H., Althouse, S. K., Ammakkanavar, N. R., Musapatika, D., Albany, C., Vaughn, D., & Hanna, N. H. (2018) · Annals of Oncology

Testicular diseases and treatmentsCancer Immunotherapy and Biomarkers

Cited by 196

Olanzapine for the Treatment of Advanced Cancer–Related Chronic Nausea and/or Vomiting: A Randomized Pilot Trial

Navari, R. M., Pywell, C. M., Le-Rademacher, J. G., White, P., Dodge, A. B., Albany, C., & Loprinzi, C. L. (2020) · JAMA Oncology

Nausea and vomiting managementCancer survivorship and care

Cited by 78

Treatment of CD30-Expressing Germ Cell Tumors and Sex Cord Stromal Tumors with Brentuximab Vedotin: Identification and Report of Seven Cases

Albany, C., Einhorn, L., Garbo, L., Boyd, T., Josephson, N., & Feldman, D. R. (2018) · The Oncologist

Testicular diseases and treatmentsLymphoma Diagnosis and Treatment

Cited by 51

Phase II Trial of Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors

Ashkar, R., Feldman, D. R., Adra, N., Zaid, M. A., Funt, S. A., Althouse, S. K., Perkins, S. M., Snow, C. I., Lazzara, K. M., Sego, L. M., et al. (2021) · Investigational New Drugs

Testicular diseases and treatmentsLymphoma Diagnosis and Treatment

Cited by 16